What is the clinical evidence from this study?

Study design: Letter. Population: new-onset heart failure (HF). Intervention: Frailty status and chronological age. Primary outcome: Cardiovascular mortality.

What does this research mean for the field?

Frailty modifies the prognostic impact of age in heart failure, but failing to account for non-cardiovascular death as a competing risk systematically overestimates cardiovascular mortality among older and high-frailty patients. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To highlight methodological limitations in assessing cardiovascular mortality across age and frailty strata in patients with new-onset heart failure.

May 18, 2026European Journal of Heart Failure

Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status’

View Full Paper

Ask AI

Bookmark

Key result

Frailty status modifies the effect of age in heart failure, where 2-year mortality in low-frailty 80-year-olds equals high-frailty 47-year-olds, though competing risks may overestimate cardiovascular death.

Population

Patients with new-onset heart failure (HF)

Design

Editorial

Authors

SBShankar BiswasIvano-Frankivsk National Medical University YSYashasvi SrivastavaIvano-Frankivsk National Medical University VCVenkateswarlu ChintagumpalaNazareth Hospital

Discussion

Member takes

Implication

Failing to account for competing risks like non-CV death in frail heart failure patients may systematically overestimate cardiovascular mortality.

Key Points

To highlight methodological limitations in assessing cardiovascular mortality across age and frailty strata in patients with new-onset heart failure.
Critiqued the analytical approach of an observational study evaluating chronological age, frailty, and mortality outcomes in new-onset heart failure.
Evaluated the statistical bias introduced by using logistic regression without accommodating non-cardiovascular deaths as competing risk events.
Treating non-cardiovascular death as censoring rather than a competing event systematically overestimates absolute cardiovascular mortality, particularly among older and more frail individuals with multiple comorbidities.
A cause-specific competing risk analysis would provide more accurate estimates and likely attenuate the apparent cardiovascular mortality gradient observed across frailty strata.

Structured PICO

Population

Patients with new-onset heart failure (HF)

Outcome

Cardiovascular (CV) mortalityhard clinical

Failing to account for competing risks like non-CV death in frail heart failure patients may systematically overestimate cardiovascular mortality.

Cite This Study

Biswas et al. (2026) conducted a letter in new-onset heart failure (HF). Frailty status and chronological age was evaluated on Cardiovascular mortality. Frailty status modifies the effect of age in heart failure, where 2-year mortality in low-frailty 80-year-olds equals high-frailty 47-year-olds, though competing risks may overestimate cardiovascular death.

synapsesocial.com/papers/6a0aadd85ba8ef6d83b70d92 https://doi.org/10.1093/ejhf/xuag164

View Full Paper

Ask AI

Bookmark

Implication

Failing to account for competing risks like non-CV death in frail heart failure patients may systematically overestimate cardiovascular mortality.

Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status’

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status’

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider